Hiroaki Kinoshita

Author PubWeight™ 54.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acute respiratory failure caused by an incarcerated right-sided adult bochdalek hernia: report of a case. Surg Today 2002 2.05
2 Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J Am Coll Surg 2002 2.00
3 Reconstructive procedure after distal gastrectomy for gastric cancer that best prevents duodenogastroesophageal reflux. World J Surg 2002 1.18
4 Laparoscopic excision of a retroperitoneal cystic lymphangioma: report of a case. Surg Today 2003 1.13
5 Surgical management of cystic hepatic neoplasms. J Gastroenterol 2003 1.08
6 Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats. Free Radic Res 2003 1.08
7 Eosinophilic enteritis presenting as acute intestinal obstruction: a case report and review of the literature. Dig Surg 2003 1.05
8 Asymptomatic thrombosis as a late complication of a retrohepatic vena caval graft performed for primary leiomyosarcoma of the inferior vena cava: report of a case. Surg Today 2002 1.04
9 Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma. World J Surg 2004 1.04
10 CD44 and VEGF expression in extrahepatic metastasis of human hepatocellular carcinoma. Hepatogastroenterology 2004 0.95
11 Self-expanding metallic stent for benign biliary strictures: seven-year follow-up. Hepatogastroenterology 2004 0.94
12 Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination. Oncol Rep 2002 0.93
13 Evaluation of the effect of portal vein embolization on liver function by (99m)tc-galactosyl human serum albumin scintigraphy. J Surg Res 2002 0.93
14 Duodenogastric reflux eradicates Helicobacter pylori after distal gastrectomy. Hepatogastroenterology 2004 0.91
15 Percutaneous transhepatic metallic stent placement for malignant portal vein stenosis. Hepatogastroenterology 2003 0.90
16 Quantitative determinations of duodenogastric reflux, prevalence of Helicobacter pylori infection, and concentrations of interleukin-8. World J Surg 2003 0.90
17 Intracystic hemorrhage with spontaneous rupture of liver cyst complicated by infection: a case report. Osaka City Med J 2003 0.89
18 Secondary hemocholecyst after radiofrequency ablation therapy for hepatocellular carcinoma. J Gastroenterol 2003 0.88
19 Plummer-Vinson syndrome successfully treated by endoscopic dilatation. J Gastroenterol Hepatol 2007 0.88
20 Different genetic alterations in rat forestomach tumors induced by genotoxic and non-genotoxic carcinogens. Carcinogenesis 2002 0.87
21 Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Ann Thorac Cardiovasc Surg 2005 0.87
22 Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients. J Am Coll Surg 2002 0.87
23 Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus. Oncol Rep 2002 0.86
24 Correlation between duodenogastric reflux and remnant gastritis after distal gastrectomy. Hepatogastroenterology 2004 0.86
25 Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 2002 0.84
26 Multicentric occurrence of hepatocellular carcinoma in patients with a somatic mutation of mitochondorial DNA and hepatitis C virus. Hepatol Res 2003 0.84
27 Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection. J Med Virol 2003 0.84
28 Surgical repair of a liver injury in a patient: accompanied with tricuspid regurgitation. Hepatogastroenterology 2003 0.84
29 Surgery for segmental primary sclerosing cholangitis. Hepatogastroenterology 2004 0.83
30 Treatment with STI571, a tyrosine kinase inhibitor, for gastrointestinal stromal tumor with peritoneal dissemination and multiple liver metastases. J Gastroenterol 2003 0.83
31 Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2002 0.82
32 Prognostic factors in patients with squamous oesophageal cancer associated with solitary lymph node metastasis after oesophagectomy and extended lymphadenectomy. Oncol Rep 2002 0.82
33 Limy bile: a case of obstructive jaundice and review of 26 cases. Osaka City Med J 2003 0.82
34 The separate-lesion type combined hepatocellular carcinoma and cholangiocarcinoma. Hepatogastroenterology 2002 0.82
35 A case of fat necrosis after breast quadrantectomy in which preoperative diagnosis was enabled by MRI with fat suppression technique. Magn Reson Imaging 2004 0.82
36 Clinicopathologic and immunohistochemical features of surgically resected small cell carcinoma of the esophagus. Oncol Rep 2002 0.82
37 Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat. Redox Rep 2002 0.81
38 Plastic iodophor drape during liver surgery operative use of the iodophor-impregnated adhesive drape to prevent wound infection during high risk surgery. World J Surg 2003 0.81
39 Usefulness of viral concentration measurement by transcription-mediated amplification and hybridization protection as a prognostic factor for recurrence after resection of hepatitis B virus-related hepatocellular carcinoma. Hepatol Res 2003 0.81
40 Indications for surgical repair of funnel chest based on indices of chest wall deformity and psychological state. Surg Today 2003 0.80
41 Appropriate surgical management of small hepatocellular carcinomas in patients infected with hepatitis C virus. World J Surg 2003 0.80
42 Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver. Hepatogastroenterology 2004 0.80
43 Successful surgical control for hepatocellular carcinoma disseminated to the peritoneum: a case report. Hepatogastroenterology 2002 0.80
44 Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B. World J Surg 2002 0.80
45 Cyclooxygenase-2 expression in the adenoma-carcinoma sequence of human gallbladder. Am J Gastroenterol 2002 0.80
46 Detection of the draining vein from hepatic focal nodular hyperplasia on three-dimensional computed tomography. Hepatogastroenterology 2004 0.79
47 Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg 2004 0.78
48 Cytologic diagnosis of estrogen and progesterone receptors in breast imprints. Acta Cytol 2002 0.78
49 Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today 2005 0.78
50 Resectable Pleomorphic Giant Cell Carcinoma of the Pancreas. Int J Gastrointest Cancer 2001 0.78
51 Power Doppler ultrasonographic diagnosis of small hepatocellular carcinomas. Dig Surg 2002 0.78
52 Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers. Hepatogastroenterology 2002 0.77
53 Clinicopathologic characteristics of small intrahepatic cholangiocarcinomas of mass-forming type. Hepatol Res 2004 0.77
54 A long-term survival case underwent repeated hepatic arterial infusion chemotherapy with portal branch ligation and wrapping of the liver using sheets for hepatocellular carcinoma. Hepatogastroenterology 2002 0.77
55 Expression of bile duct-type cytokeratin in hepatocellular carcinoma in patients with hepatitis C virus and prior hepatitis B virus infection. Cancer Lett 2002 0.77
56 [A case of synchronous esophageal and gastric cancer successfully treated by combination TS-1/CDDP therapy with irradiation]. Gan To Kagaku Ryoho 2004 0.77
57 Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma. Hepatogastroenterology 2002 0.77
58 Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma. Hepatogastroenterology 2003 0.77
59 High susceptibility of p53 knockout mice to esophageal and urinary bladder carcinogenesis induced by N, N-dibutylnitrosamine. Cancer Lett 2003 0.77
60 Effects of alanine in patients with advanced primary biliary cirrhosis: preliminary report. Hepatol Res 2003 0.77
61 Limitation of portal vein embolization for extension of hepatectomy indication in patients with hepatocellular carcinoma. Hepatogastroenterology 2004 0.77
62 p53 null mutations detected by a p53 yeast functional assay predict a poor outcome in young esophageal carcinoma patients. Int J Oncol 2002 0.77
63 Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2002 0.77
64 A clinicopathological study of inflammatory pseudotumors of the liver with special reference to vessels. Hepatogastroenterology 2004 0.76
65 [Early phase II dose-finding study of exemestane in postmenopausal patients with advanced/recurrent breast cancer]. Gan To Kagaku Ryoho 2002 0.76
66 Prognostic factors in patients with carcinoma of the papilla of Vater. Hepatogastroenterology 2002 0.76
67 Bronchoscopic ultrasonography for staging supracarinal esophageal squamous cell carcinoma: impact on outcome. World J Surg 2003 0.76
68 A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker. Hepatogastroenterology 2004 0.76
69 Effect of H. pylori on COX-2 expression in gastric remnant after distal gastrectomy. Hepatogastroenterology 2004 0.76
70 Cimetidine reduces impairment of cellular immunity after transcatheter arterial embolization in patients with hepatocellular carcinoma. Hepatogastroenterology 2003 0.76
71 Multifocal hepatocellular carcinoma in patients undergoing living-related liver transplantation. Hepatogastroenterology 2003 0.76
72 Ambulatory intraesophageal bilirubin monitoring in Japanese patients with gastroesophageal reflux. J Gastroenterol 2002 0.75
73 Weak enhancing effects of simultaneous ethanol administration on chemically induced rat esophageal tumorigenesis. Oncol Rep 2002 0.75
74 [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay]. Gan To Kagaku Ryoho 2002 0.75
75 Retrospective study of conservation surgery for breast cancer with or without axillary dissection. Osaka City Med J 2002 0.75
76 Pseudoaneurysm of the dorsal pancreatic artery with obstruction of the celiac axis after pancreatoduodenectomy: report of a case. Surg Today 2005 0.75
77 Curative resection of a huge bile duct cancer without pancreatoduodenectomy. Hepatogastroenterology 2004 0.75
78 Hepatocellular carcinoma fed by an aberrant posterior right hepatic artery. Hepatogastroenterology 2003 0.75
79 Effects of marker for hepatic fibrosis and viral status on recurrence after resection of hepatitis B virus-related hepatocellular carcinoma. Hepatogastroenterology 2003 0.75
80 The distribution of secretory immunoglobulin A in the liver of patients with hepatolithiasis. Osaka City Med J 2002 0.75
81 Intrahepatic cystadenocarcinoma with pleural dissemination: a case report. Osaka City Med J 2003 0.75
82 Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma. Surg Today 2004 0.75
83 Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma. Hepatogastroenterology 2003 0.75
84 Usefulness of three-dimensional computed tomography in a living-donor extended right lobe liver transplantation. Liver Transpl 2002 0.75
85 Effects of FK506 on acute allograft rejection in transplanted rat heart: the role of mitogen-activated protein kinases, AP-1 and NF-kappaB. Osaka City Med J 2003 0.75
86 [A case of gastric cancer in the stomach wall used for mediastinal reconstruction after esophagectomy in which surgery was abandoned due to advanced age and complications but TS-1 was useful]. Gan To Kagaku Ryoho 2002 0.75
87 [Thoracoscopic esophagectomy]. Nihon Geka Gakkai Zasshi 2002 0.75
88 Serum concentration of type IV collagen 7S domain as a marker for increased risk of recurrence after liver resection for hepatocellular carcinoma. Dig Surg 2003 0.75
89 Effect of duodenogastric reflux on N-methyl-N'-nitro-N-nitrosoguanidine-induced glandular stomach tumorigenesis in Helicobacter pylori-infected Mongolian gerbils. Oncol Rep 2004 0.75
90 Usefulness of biodegradable absorbable rib connecting pins in thoracoabdominal hepatectomy. Hepatogastroenterology 2003 0.75
91 [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2001 and March 2002]. Jpn J Antibiot 2003 0.75
92 Surgical repair of esophagobronchial fistula caused by radiation injury. Hepatogastroenterology 2004 0.75
93 [Remnant gastric cancer in which prolonged no change status was maintained with low-dose TS-1--a case report]. Gan To Kagaku Ryoho 2003 0.75
94 Refractory empyema caused by an intraoperative rib fracture sustained during esophagectomy: report of a case. Surg Today 2003 0.75
95 [Resection of esophageal cancer infiltrating the left main bronchus following complete response to preoperative radiochemotherapy--a case report]. Gan To Kagaku Ryoho 2003 0.75
96 Living-related liver transplantation in a patient with end-stage hepatolithiasis and a biliary-bronchial fistula. Hepatogastroenterology 2004 0.75
97 Phase I studies of nogitecan hydrochloride for Japanese. Int J Clin Oncol 2002 0.75
98 Effects of prostaglandin E1 infused via the superior mesenteric artery on partially resected, dearterialized canine liver. Osaka City Med J 2003 0.75
99 [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2002 and March 2003]. Jpn J Antibiot 2004 0.75
100 [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2000 and March 2001]. Jpn J Antibiot 2002 0.75
101 Polyamine metabolism and recurrence after resection for hepatocellular carcinoma. Hepatogastroenterology 2004 0.75
102 The prognostic factors after radical esophagectomy for esophageal cancer with positive preoperative CEA. Hepatogastroenterology 2004 0.75
103 Chest wall resection in general thoracic surgery. Osaka City Med J 2002 0.75
104 Distant metastatic recurrence after hepatic resection for hepatocellular carcinoma. Osaka City Med J 2002 0.75
105 Evaluation of blood flow by color Doppler sonography in free jejunal interposition grafts for cervical esophageal reconstruction. World J Surg 2005 0.75
106 Levofloxacin for prophylaxis in breast cancer surgery compared with ofloxacin. Jpn J Antibiot 2002 0.75
107 Portal thrombosis due to intrahepatic cholangiocarcinoma following successful treatment for hepatocellular carcinoma. Hepatogastroenterology 2003 0.75
108 Laparoscopic splenectomy for variceal bleeding with non-cirrhotic portal vein thrombosis: a case report. Hepatogastroenterology 2003 0.75
109 Type IV collagen 7s domain as a predictor of poor efficacy of portal vein embolization before major hepatectomy. Surg Today 2005 0.75
110 [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between April 1999 and March 2000]. Jpn J Antibiot 2002 0.75
111 Esophageal tuberculosis presenting with an appearance similar to that of carcinoma of the esophagus. J Gastroenterol 2003 0.75
112 Percutaneous management of bile duct injuries after cholecystectomy. Hepatogastroenterology 2002 0.75
113 Recovery of hepatic function determined by cytochrome P450-dependent drug metabolism lags after compensatory hepatic volume changes after portal vein ligation in rats. J Surg Res 2006 0.75
114 Risk factors for intractable pleural effusion after liver resection. Osaka City Med J 2004 0.75
115 [A case of Barrett's esophageal cancer showing good response to combined chemotherapy with TS-1, CDDP and radiotherapy]. Gan To Kagaku Ryoho 2003 0.75